Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept Long-term Follow-up in PAH (SOTERIA)
NCT04796337Phase 3Active, not recruiting
- Start
- May 2021
- Primary completion
- Feb 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 28
01
Overview
A Phase 3 trial of sotatercept in pulmonary arterial hypertension (PAH). Started May 2021; status: active, not recruiting.
02
Drugs
sotatercept
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04796337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04796337.